Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Return on Equity: 2024-2025

Historic Return on Equity for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to -0.07%.

  • Immunocore Holdings' Return on Equity rose 5.00% to -0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.07%, marking a year-over-year increase of 5.00%. This contributed to the annual value of -0.14% for FY2024, which is 2.00% up from last year.
  • Immunocore Holdings' Return on Equity amounted to -0.07% in Q3 2025, which was down 40.57% from -0.05% recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Return on Equity registered a high of -0.05% during Q2 2025, and its lowest value of -0.17% during Q1 2024.
  • Moreover, its 2-year median value for Return on Equity was -0.13% (2024), whereas its average is -0.11%.
  • Data for Immunocore Holdings' Return on Equity shows a peak YoY rose of 11bps (in 2025) over the last 5 years.
  • Immunocore Holdings' Return on Equity (Quarterly) stood at -0.14% in 2024, then rose by 5bps to -0.07% in 2025.
  • Its Return on Equity was -0.07% in Q3 2025, compared to -0.05% in Q2 2025 and -0.06% in Q1 2025.